APAMISTAMAB-B10-ASTATINE AT-211
UNII 3BVH1ZF9JX

Substance Identification & Data

This profile provides standardized clinical and technical data for Apamistamab-b10-astatine At-211, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3BVH1ZF9JX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3BVH1ZF9JX
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
APAMISTAMAB-B10-ASTATINE AT-211
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C133190
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Apamistamab-b10-astatine At-211. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

211AT-BC8-B10
APAMISTAMAB-B10-ASTATINE AT-211
AT 211 ANTI-CD45 MONOCLONAL ANTIBODY BC8-B10
BC8-B10 IS A RADIOIMMUNOCONJUGATE THAT CONTAINS ANTI-CD45 MONOCLONAL ANTIBODY BC8 WITH ITS LYSINE SIDE GROUPS CONJUGATED WITH DECOBORATE AND LABELED WITH ASTATINE
BC8-B10-ASTATINE AT-211

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus